Search

everythinglearnresearchcommunity

for

Search:↓

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Microneedling with platelet-rich plasma helps dog hair regrow faster than microneedling alone.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

A 16-year-old girl with autoimmune hemolytic anemia and deep vein thrombosis improved with treatment, possibly indicating systemic lupus erythematosus.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Teledermatology is highly accurate for diagnosing inflammatory skin conditions.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.